Dr. Sima Rozati, assistant professor of dermatology at the Johns Hopkins School of Medicine, discussed challenges in cutaneous T-cell lymphoma (CTCL) during the 2022 Murtha Cancer Center Skin Cancer Summit held virtually June 2. "When managing CTCL patients, it’s important to make the right diagnosis, [and] staging is the only validated prognostic factor. Also, determine the goals of therapy, consider the patient’s quality of life, [and] reassess and restage with new cutaneous and extra cutaneous findings,” she stated.
| Date Taken: | 06.09.2022 |
| Date Posted: | 06.09.2022 14:38 |
| Photo ID: | 7262877 |
| VIRIN: | 220609-A-AB123-1003 |
| Resolution: | 320x320 |
| Size: | 24.53 KB |
| Location: | US |
| Web Views: | 32 |
| Downloads: | 4 |
This work, Skin Cancer Summit Focuses on Prevention, Detection, Treatment [Image 5 of 5], must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.